Samira Ghorbanigazar

Biography

My interest in the field of  MS has led me to pursue a postdoctoral fellowship with the internationally acclaimed MS researcher, Prof. Wee Yong, at one of the most significant and forward-looking MS research centers in Canada. I am honoured to be part of a great team working on new therapies in MS and remyelination. Research has become my passion and my desire is to introduce an effective therapy that can promote tissue repair and block progression of MS.

Publications

Erin L. Stephenson, Ping Zhang, Samira Ghorbani, Aixia Wang, Jiamin Gu, Michael B. Keough, Khalil Sherali Rawji, Claudia Silva, V. Wee Yong, Chang-Chun Ling. (2019). Targeting the Chondroitin Sulfate Proteoglycans: Evaluating Fluorinated Glucosamines and Xylosides in Screens Pertinent to Multiple Sclerosis. ACS Central Science. https://www.ncbi.nlm.nih.gov/pubmed/31404231

Ghorbani S*, Shakerian L*, Talebi F, Noorbakhsh F. * Co First Authors. (2018). MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology.https://www.ncbi.nlm.nih.gov/pubmed/30196828

Ghorbani S, Talebi F, Chan WF, Masoumi F, Vojgani M, Power C and Noorbakhsh F. (2017). MicroRNA-181 Variants Regulate T Cell Phenotype in the Context of AutoimmuneNeuroinflammation.Frontiers in Immunology. https://www.ncbi.nlm.nih.gov/pubmed/28769921

Ghorbani S, Talebi F, Ghasemi S, Jahanbazi Jahan Abad A, Vojgani M, Noorbakhsh F. (2017). miR-181 interacts with signalling adaptor molecule DENN/MADD and enhances TNF-induced cell death. PLOS ONE. https://www.ncbi.nlm.nih.gov/pubmed/28323882

Talebi F, Ghorbani S, Chan WF, Masoumi F, Vojgani M, Power C and Noorbakhsh F. (2017). MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis. https://www.ncbi.nlm.nih.gov/pubmed/28302134